Solutions

Online Inquiry

Global Services. (Creative Biolabs Authorized)

Preclinical Trial-on-Chip Pancreatic "Cold Tumor" Model Customization Service Powered CAR-T Development

Online Inquiry

Background Service What we can offer Workflow HighlightsFAQs Related ServicesContact

Poor T-cell infiltration, dense stromal barriers, and highly immunosuppressive tumor microenvironments remain major obstacles in pancreatic ductal adenocarcinoma research. Our Preclinical Trial-on-Chip Pancreatic "Cold Tumor" Model Customization Service addresses these challenges by enabling accurate validation of CAR-T efficacy and optimization of infiltration strategies using advanced microfluidic platforms and patient-derived 3D co-culture systems. This human-relevant, physiologically faithful model bridges the gap between static 2D assays and costly animal studies, providing actionable insights that reduce clinical failure risk and accelerate the development of next-generation cell therapies.

Introduction

Pancreatic ductal adenocarcinoma is characterized by dense desmoplastic stroma, abnormal vasculature, and strong immunosuppression, leading to poor CAR-T penetration and activity. Recent literature highlights microphysiological tumor-on-chip systems as reliable tools to model these barriers and capture dynamic immune-tumor interactions. Integrating such models into CAR-T development enables more predictive preclinical evaluation and supports rational therapeutic optimization.

Biochip engineering. (OA Literature) Fig.1 Design of a biochip.¹

Service

Our service provides a high-fidelity, biomimetic platform designed to replicate the "fortress" architecture of pancreatic cold tumors. It directly addresses the central challenge of solid tumor CAR-T therapy, physical and biochemical exclusion within the tumor microenvironment. By engineering a customizable microfluidic chip incorporating dense extracellular matrix and immunosuppressive cellular components, the platform enables physiologically relevant modeling of stromal barriers. Real-time visualization and quantitative analysis allow you to assess CAR-T trafficking, stromal penetration, target recognition, and functional cytotoxicity, generating actionable insights for candidate optimization and translational decision making.

Discover How We Can Help - Request a Consultation to design a chip model.

What We Can Offer

Creative Biolabs provides a flexible and non-infringing technology framework, including:

Analysis of Preclinical Trial-on-Chip Pancreatic 'Cold Tumor' Model Customization. (Creative Biolabs Original)

Our Workflow

To ensure your model is tailored to your specific therapeutic target, we follow a rigorous, high-throughput manufacturing and testing protocol:

Workflow of Preclinical Trial-on-Chip Pancreatic 'Cold Tumor' Model Customization. (Creative Biolabs Original)

Our Advantages

Advanced 3D tumor microenvironment reconstruction incorporating key immunosuppressive and stromal components.
Physiologically relevant flow conditions to accurately evaluate CAR-T trafficking, infiltration, and cytotoxicity.
High-content, real-time imaging for dynamic assessment of CAR-T behavior and tumor response.
Integrated functional readouts, including infiltration efficiency, tumor killing kinetics, and immune activation profiles.
Comprehensive data analysis and visualization packages suitable for internal decision-making and regulatory discussions.

FAQs

Q1: Can I use my own patient-derived organoids in the customized chip?

A1: Absolutely. Our platform is designed for modularity. You can ship your PDOs to us, and we will integrate them with our standardized or customized TME components to create a personalized testing environment.

Q2: What imaging capabilities are provided with the service?

Q2: We provide high-resolution confocal and fluorescence imaging. We can provide time-lapse videos of T-cell migration and quantify parameters like "Distance to Tumor Core" and "Infiltration Velocity" using our AI-driven image analysis software.

Q3: How does the "Trial-on-Chip" compare to traditional animal models?

A3: While animal models provide systemic data, they are often poor predictors of human T-cell behavior due to species-specific immune differences. Our chips use 100% human cells and allow for real-time observation of the "human" immune synapse, often providing more actionable data in a fraction of the time.

Related Services

BM-on-Chip Model Customization

We offer tailored bone marrow-on-chip models that recreate the hematopoietic and stromal niche specifically for CAR-T research. By mimicking the marrow's unique architecture, this platform provides a high-fidelity environment to evaluate CAR-T expansion, long-term persistence, and safety before moving to clinical trials.

Learn More →

Preclinical Trial-on-Chip GBM Special Customization

To tackle the complexities of Glioblastoma, our GBM-specific chips integrate blood-brain barrier (BBB) features, hypoxia, and immunosuppressive niches. This specialized setup allows researchers to realistically track CAR-T cell penetration, survival, and antitumor potency within the challenging brain microenvironment.

Learn More →

Preclinical Trial-on-Chip Hepatocellular Carcinoma & Metastasis Solution

Our HCC and metastasis platforms accurately replicate the liver's microenvironment and metastatic sites. These chips enable real-time monitoring of CAR-T infiltration, activation, and cytotoxicity, offering the physiological insights needed to predict how therapies will overcome dense tumor barriers and prevent spread.

Learn More →

Partner with Us

Creative Biolabs provides a revolutionary approach to overcoming the "Cold Tumor" barrier in pancreatic cancer. By combining microfluidic precision with deep biological expertise, our Preclinical Trial-on-Chip Customization Service ensures that your CAR-T candidates are tested against the most realistic human barriers available today. Don't let your research be limited by outdated models. Please contact our team to discuss your project and for further information.

Reference

Deipenbrock, Alina et al. "Modelling of the multicellular tumor microenvironment of pancreatic ductal adenocarcinoma (PDAC) on a fit-for-purpose biochip for preclinical drug discovery." Lab on a chip vol. 25,9 2168-2181. 29 Apr. 2025. Distributed under Open Access License CC BY 4.0, without modification. https://doi.org/10.1039/D4LC01016G

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.